Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trial duration and follow-up.

E Perucca1

  • 1Clinical Pharmacology Unit, University of Pavia, Piazza Botta 10, 27100, Pavia, Italy. perucca@unipv.it

Epilepsy Research
|July 20, 2001
PubMed
Summary
This summary is machine-generated.

Long-term studies are crucial for evaluating new antiepileptic drugs (AEDs) and their safety. Current trial durations are often insufficient, necessitating a balance between data needs and industry investment for better epilepsy treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Midazolam vs diazepam in prolonged seizures in children: A pharmacoeconomic approach.

Acta neurologica Scandinavica·2017
Same author

Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis.

Neuroscience·2012
Same author

Nifedipine versus fenoterol in the management of preterm labor: a randomized, multicenter clinical study.

Gynecologic and obstetric investigation·2012
Same author

Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy.

Neurology·2012
Same author

Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures.

Epilepsy research·2011
Same author

Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.

Neurology·2007

Area of Science:

  • Pharmacology
  • Clinical Trials
  • Neurology

Background:

  • Epilepsy and seizure disorders are chronic conditions requiring long-term antiepileptic drug (AED) treatment.
  • Assessing new AEDs necessitates long-term data on efficacy, tolerance, and safety.
  • Balancing extensive data requirements with industry investment is crucial for developing new epilepsy treatments.

Purpose of the Study:

  • To evaluate the adequacy of current clinical trial designs for antiepileptic drugs (AEDs).
  • To propose recommendations for optimizing long-term AED trial methodologies.
  • To address ethical considerations in AED clinical trial design.

Main Methods:

  • Review of existing methodologies for add-on, monotherapy, and active-controlled AED trials.

Related Experiment Videos

  • Analysis of recommended durations and endpoints for assessing AED efficacy and safety.
  • Consideration of ethical implications of current trial practices, including unblinding procedures.

    • Main Results:

    • Current monotherapy trial durations (weeks) are often too short and rely on seizure deterioration as an endpoint.
    • Add-on studies should offer indefinite open-label treatment with prospective safety data collection.
    • Active-control monotherapy trials for newly diagnosed patients require longer durations (e.g., 2 years) for robust efficacy and safety assessment.

    Conclusions:

    • Existing AED trial designs, particularly for monotherapy, require significant revision to ensure adequate long-term efficacy and safety evaluation.
    • Ethical concerns regarding study designs, especially in refractory patients and unblinding procedures, need to be addressed.
    • Optimized trial designs, including longer durations and prospective data collection, are essential for advancing epilepsy treatment.